Market Snapshot

3D Cell Culture Market: By Technology, Application, End-User and Region

Market Synopsis:

Global 3D Cell Culture market is valued at USD 905.8 Million in 2021 and is projected to attain a value of USD 2,051.5 Million by 2028 at a CAGR of 15.1% during the forecast period, 2022–2028. 3D Cell Culture are commonly utilised in research that require in vivo model systems to assess the effects of a foreign substance on bodily tissues and organs since they can precisely resemble the morphology and microarchitecture of organs. In addition, the utilisation of biomimetic tissue constructs to build 3D organotypic structures prompted a large number of research organisations to embrace 3-dimensional cell culture techniques. Furthermore, using 3D tissue-engineered models for Covid-19, cancer, and other clinical illnesses has emerged as a viable alternative to traditional methods. In comparison to 2D approaches, this has a lot of promise in terms of delivering a reasonably simple and inexpensive in vitro tumor-host environment.

The pandemic of COVID-19 is predicted to have a major influence on the market. Researchers working on COVID-19 must explore in vitro the processes of systemic repercussions of cell cultures and test prospective therapeutics in a physiological milieu using appropriate matrices for 3D Cell Culture and suitable for air-liquid interface culture. The utilisation of 3D Cell Culture in COVID-19 research is primarily for this reason.

Growing Prevalence of Cancer

Cancer genomics is one of the most important applications of 3D Cell Culture market. According to GLOBOCAN, cancer cases would increase to almost 30 million by 2040, up from 19.3 million cases and ten million cancer deaths in 2020. Because of the rising frequency of this disease, more study is needed for diagnosis and treatment; 3D Cell Culture is an important aspect of this research. Individual cell analysis allows for accurate illness diagnosis and therapy efficacy monitoring. In breast cancer and other malignancies, 3D Cell Culture aids in the identification of helper T-cells, the detection of DNA content, and the monitoring of tumour cell proliferation.

High Cost of Products

Because of the requirement to maintain high-quality standards (the use of high-grade, expensive items) and adhere to regulatory rules, cell biology research has a high cost. However, due to funding constraints, research and academic laboratories are unable to purchase such expensive instruments. In addition, the total cost of ownership of these instruments rises as a result of maintenance charges and a variety of additional indirect expenses. This is a key stumbling block to the widespread use of flow cytometers and microfluidic devices in clinical and research settings.

The 3D Cell Culture market scope can be tabulated as below:

Market Segmentation:

Global 3D Cell Culture market is segmented on the basis of Technology into Scaffold based, Scaffold free and 3D Bioreactors. Based on Application into Cancer, Tissue engineering & Immunohistochemistry, Drug development, Stem cell research and Others. By End-Use into Biotechnology and pharmaceutical industries, Research laboratories and institutes, Hospitals and diagnostic centers and Others. Based on region, the 3D Cell Culture market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

North America to Continue Dominating the 3D Cell Culture Market

In 2020, North America dominated the 3D Cell Culture market over the forecast period.

Because of the availability of private and government funding for the development of advanced 3D cell culture models, high healthcare spending, and the presence of a large number of universities and research organisations investigating various stem cell-based approaches, the region will maintain its leadership position throughout the forecast period. Researchers from the Mayo Clinic and the Terasaki Institute in the United States discovered transparent hydrogels that can be used to monitor and manage haemorrhage in December 2020.

Key Players:

Key participants operating in the 3D Cell Culture market are: Corning Incorporated, Lonza AG, Thermo Fisher Scientific, Merck KGaA, MIMETAS BV are the major companies operating in Global 3D Cell Culture Market.

The 3D Cell Culture market is segmented as follows:

• Technology
  • Scaffold Based
  • Scaffold Free
  • 3D Bioreactors